Literature DB >> 8645840

Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit.

R A Venezia1, F J Scarano, K E Preston, L M Steele, T P Root, R Limberger, W Archinal, M A Kacica.   

Abstract

Klebsiella oxytoca that produced extended-spectrum beta-lactamase (ESBL) and were resistant to ceftazidime were isolated from infants in a neonatal intensive care unit (NICU). During a 30-week period, 3 infants developed infections and an additional 60 infants were colonized with these bacteria. The molecular typing data suggested transmission of a single strain of ceftazidime-resistant K. oxytoca among 48 of the 63 infants. The ESBL of 46 of the 48 similar isolates, 14 of the remaining 15 isolates, and 6 other Enterobacteriaceae appeared to be associated with a conjugative plasmid of approximately 85 kb. The ESBL gene was cloned, and DNA sequencing confirmed that the ESBL was an SHV-5. Hybridization data suggested that the SHV-5 gene was transmitted to other Enterobacteriaceae in vivo. The spread of the ESBL was reduced through adherence to infection control practices.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8645840     DOI: 10.1093/clinids/21.4.915

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase in the premature intensive care unit of a Hungarian hospital.

Authors:  D Szabó; Z Filetóth; J Szentandrássy; M Némedi; E Tóth; C Jeney; G Kispál; F Rozgonyi
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Nucleotide sequence of the chromosomal ampC gene of Enterobacter aerogenes.

Authors:  K E Preston; C C Radomski; R A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors:  Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

4.  Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece.

Authors:  E Lebessi; H Dellagrammaticas; P T Tassios; L S Tzouvelekis; S Ioannidou; M Foustoukou; N J Legakis
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.

Authors:  S W Wu; K Dornbusch; G Kronvall
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

7.  Survey of plasmid-associated genetic markers in enterobacteriaceae with reduced susceptibilities to cephalosporins.

Authors:  Karen E Preston; Eileen M Graffunder; Ann M Evans; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 8.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan.

Authors:  P Y Liu; J C Tung; S C Ke; S L Chen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Choice of antibiotics in late neonatal sepsis in the extremely low birth weight infant.

Authors:  Tara R Allen; Orlando P da Silva
Journal:  Can J Infect Dis       Date:  2003-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.